{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-099416","form_type":"8-K","ticker":"PLYX","cik":"0002075320","company_name":"Polaryx Therapeutics, Inc.","filed_at":"2026-09-11T23:59:23+00:00","discovered_at":"2026-09-14T10:05:00.370364+00:00","generated_at":"2026-09-14T10:05:35.502613+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Polaryx shareholders re-elect Alex Yang, Mitchel Berger as Class I directors","bullets":["Alex Yang and Mitchel Berger re-elected as Class I directors at Sept 10, 2026 annual meeting.","Each director received 30,072,137 votes for, 332 withheld, with 472,610 broker non-votes.","Ratification of Grant Thorton LLP as auditor for FY2026 approved: 30,510,106 for, 34,973 against.","Directors will serve until the 2029 annual meeting of stockholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-099416","json":"https://secwatch.observer/filing/0001213900-26-099416.json","markdown":"https://secwatch.observer/filing/0001213900-26-099416.md","text":"https://secwatch.observer/filing/0001213900-26-099416.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/0001213900-26-099416-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/ea0305352-8k_polaryx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T10:05:35.502613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}